Now, we will propose the following hypothesis: miR-186 expression is downregulated in the progression of CML, leading to the upregulation of target gene—DDX43 in CML; DDX43 further upregulates the expression of H19 through demethylation. Here, DDX43 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.